Skip to content

The efficacy of a microwave device for treating axillary hyperhidrosis: Split-patient (1Pass vs 2Pass) comparative study

The efficacy of a microwave device for treating axillary hyperhidrosis: Split-patient (1Pass vs 2Pass) comparative study - The efficacy of a microwave device for treating axillary hyperhidrosis

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
JPRN
Registry ID
JPRN-UMIN000027772
Enrollment
32
Registered
2017-06-16
Start date
2017-12-01
Completion date
Unknown
Last updated
2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

primary axillary hyperhidrosis

Interventions

Once per treatment Twice per treatment

Sponsors

Tokyo Medical and Dental University Hospital
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: (1) over 20 years old (2) hyperhidrosis in both axillary bilateral symmetry Axillary hyperhidrosis is the case where locally excessive perspiration is observed for more than 6 months without obvious cause and more than 2 of the following 6 symptoms apply 1)appear to be 25 years or younger 2)Sweating is seen in symmetry 3)Sweating stops while sleeping 4)episodes of multiple perspiration at least once in a week 5)have a family history 6)to interfere with everyday life by them (3) perspiration from each axilla is 50 mg / 5 minutes or more (4) HDSS 3 or 4

Exclusion criteria

Exclusion criteria: (1) Secondary hyperhidrosis (2) Frey syndrome (3) Topical application of aluminum chloride within 4 weeks of consent acquisition (4) Local injection of botulinum toxin type A was conducted within one year of consent acquisition (5) Oral intake of anticholinergic drug within 2 weeks of acquiring consent (6) I underwent surgery on the axillary part (7) Serious underlying disease (history of xylocaine shock) (8) Diseases requiring systemic administration such as steroids (9) Systemic diseases such as collagen diseases that have impaired wound healing (10) any type of pacemaker implantation

Design outcomes

Primary

MeasureTime frame
Comparison of sweating amount by gravimetric method: amount of perspiration at 24 weeks after treatment between 1 or 2 pass groups

Countries

Japan

Contacts

Public ContactTakichi Munetsugu

Tokyo Medical and Dental University Hospital Dermatology

mtakderm@tmd.ac.jp03-5803-5286

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026